Market Cap: $30.11B
Market Cap: $30.11B
Open
$286.29
Prev. Close
$368.24
High
$287.04
Low
$282.58
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices.
Labcorp Holdings Inc. trades on the New York Stock Exchange under the ticker LH, priced in USD.
Labcorp Holdings Inc. has a market capitalisation of $30.11B, based on its latest share price.
LH trades at 30.19 times its trailing 12-month earnings.
Over the past 52 weeks LH has traded between $245.00 and $375.10.
Yes. Labcorp Holdings Inc.'s dividend yields 0.78% at the current share price, paying out 24% of its earnings.
Profitable, with a net margin of 6.9% over the last 12 months.
The analyst consensus rating for LH is Buy. Analysts' average 12-month price target of $353.15 implies 5% downside.
Adam H. Schechter is the CEO of Labcorp Holdings Inc., which is headquartered in Burlington.
Generated automatically from reported financial data. General information only, not financial advice.

Labcorp Holdings Inc. is navigating a complex landscape in the diagnostic testing market, characterized by strong revenue growth, the introduction of innovative products, and the looming threat of red…

Labcorp (Ticker: LH) has announced the nationwide availability of ColoSense®, a groundbreaking at-home colorectal cancer screening test that utilizes RNA technology. As the first of its kind approved…

Laboratory Of America Holdings (Ticker: LH) makes significant advances in precision medicine, particularly in the oncology sector, through notable initiatives that highlight its commitment to improvin…

Laboratory Of America Holdings (Ticker: LH) collaborates with the Alliance for Clinical Trials in Oncology to enhance genetic testing for colorectal cancer, addressing a critical gap in patient care.…